ROFLUMILAST vs ZORYVE
Independent side-by-side comparison.
Rating
66/100
New
Pharmacy pays
~$10.09 /30
~$10.09 /30
Type
RX
RX
Active ingredient
ROFLUMILAST
ROFLUMILAST
Dosage forms
Tablet
Spray/Inhaler, Topical
Drug class
Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitor
Boxed warning
None
None
Treats
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Frequently asked questions
Which is cheaper, Roflumilast or Zoryve?
Pharmacies pay about the same to acquire either one — roughly $10.09 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Roflumilast and Zoryve?
Both Roflumilast and Zoryve share the active ingredient Roflumilast.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.